Guidelines for the Treatment of Latent Tuberculosis Infection: Recommendations from the National Tuberculosis Controllers Association and CDC, 2020
Top Cited Papers
- 14 February 2020
- journal article
- research article
- Published by Centers for Disease Control MMWR Office in MMWR. Recommendations and Reports
- Vol. 69 (1), 1-11
- https://doi.org/10.15585/mmwr.rr6901a1
Abstract
These updated 2020 latent tuberculosis infection treatment guidelines include the recommended treatment regimens that comprise three preferred rifamycin-based regimens and two alternative monotherapy regimens with daily isoniazid.Keywords
This publication has 93 references indexed in Scilit:
- GRADE guidelines: 14. Going from evidence to recommendations: the significance and presentation of recommendationsJournal of Clinical Epidemiology, 2013
- Efficacy of a Six-Month versus a 36-Month Regimen for Prevention of Tuberculosis in HIV-Infected Persons in India: A Randomized Clinical TrialPLOS ONE, 2012
- Isoniazid vs. Rifampin for Latent Tuberculosis Infection in Jail InmatesJournal of Correctional Health Care, 2012
- Three Months of Rifapentine and Isoniazid for Latent Tuberculosis InfectionNew England Journal of Medicine, 2011
- The Cochrane Collaboration's tool for assessing risk of bias in randomised trialsBMJ, 2011
- Primary Isoniazid Prophylaxis against Tuberculosis in HIV-Exposed ChildrenNew England Journal of Medicine, 2011
- New Regimens to Prevent Tuberculosis in Adults with HIV InfectionNew England Journal of Medicine, 2011
- Epidemiological benefits of more-effective tuberculosis vaccines, drugs, and diagnosticsProceedings of the National Academy of Sciences, 2009
- GRADE: an emerging consensus on rating quality of evidence and strength of recommendationsBMJ, 2008
- Effect of isoniazid prophylaxis on mortality and incidence of tuberculosis in children with HIV: randomised controlled trialBMJ, 2006